{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:17:28Z","timestamp":1648822648871},"reference-count":21,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3899\/jrheum.170200","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T11:40:22Z","timestamp":1496317222000},"page":"717-719","source":"Crossref","is-referenced-by-count":0,"title":["The Economic Value of Genetic Testing for Tolerance of Allopurinol in Gout"],"prefix":"10.3899","volume":"44","author":[{"given":"GEMMA ELIZABETH","family":"SHIELDS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"2018112909370428000_44.6.717.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204647"},{"key":"2018112909370428000_44.6.717.2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0288-5"},{"key":"2018112909370428000_44.6.717.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.02.004"},{"key":"2018112909370428000_44.6.717.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket265"},{"key":"2018112909370428000_44.6.717.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"},{"key":"2018112909370428000_44.6.717.6","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.1.6"},{"key":"2018112909370428000_44.6.717.7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000154"},{"key":"2018112909370428000_44.6.717.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.01.004"},{"key":"2018112909370428000_44.6.717.9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ACI.0000000000000286","article-title":"Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions","volume":"16","author":"Wang","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2018112909370428000_44.6.717.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151476"},{"key":"2018112909370428000_44.6.717.11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-118"},{"key":"2018112909370428000_44.6.717.12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0378-6323.148566","article-title":"Drug eruptions induced by allopurinol associated with HLA-B*5801","volume":"81","author":"Zeng","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2018112909370428000_44.6.717.13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12389"},{"key":"2018112909370428000_44.6.717.14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22409"},{"key":"2018112909370428000_44.6.717.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094294"},{"key":"2018112909370428000_44.6.717.16","doi-asserted-by":"crossref","unstructured":"Jutkowitz E Dubreuil M Lu N Kuntz KM Choi HK . The cost-effectiveness of HLA-b*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum 2016 Nov 1 (E-pub ahead of print).","DOI":"10.1016\/j.semarthrit.2016.10.009"},{"key":"2018112909370428000_44.6.717.17","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2217\/pgs.15.125","article-title":"Cost\u2013effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore","volume":"16","author":"Dong","year":"2015","journal-title":"Pharmacogenomics"},{"key":"2018112909370428000_44.6.717.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2251"},{"key":"2018112909370428000_44.6.717.19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40273-016-0397-9","article-title":"A systematic review of economic evaluations of pharmacogenetic testing for prevention of adverse drug reactions","volume":"34","author":"Plumpton","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"2018112909370428000_44.6.717.20","first-page":"115","article-title":"Economic evaluations of personalized medicine: existing challenges and current developments","volume":"8","author":"Shabaruddin","year":"2015","journal-title":"Pharmgenomics Pers Med"},{"key":"2018112909370428000_44.6.717.21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T11:05:04Z","timestamp":1569409504000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3899\/jrheum.170200"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170200","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}